Suchergebnisse - (Person:"Jensen, Alexandra")

PubPharm (23)

1

Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC

enthalten in: British journal of cancer | 2020

von Rong, C. | Muller, M. | Xiang, F. | +6

2

The Phase 1/2 ACCEPT Trial : Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck

enthalten in: International journal of radiation oncology, biology, physics | 2020

von Adeberg, S. | Akbaba, S. | Lang, K. | +12

3

Radiochemoimmunotherapy with intensity-modulated concomitant boost : interim analysis of the REACH trial

enthalten in: Radiation oncology (London, England) | 2012

von Jensen, A. | Krauss, J. | Potthoff, K. | +5

4

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

enthalten in: Radiation oncology | 2012

von Jensen, A. | Krauss, J. | Potthoff, K. | +5

5

A clinical concept for interfractional adaptive radiation therapy in the treatment of head and neck cancer

enthalten in: International journal of radiation oncology, biology, physics | 2012

von Jensen, A. | Nill, S. | Huber, P. | +3

6

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

in: Radiation Oncology | 2012

von Jensen Alexandra D | Krauss Jürgen | Potthoff Karin | +5

7

Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

enthalten in: Radiation oncology (London, England) | 2011

von Jensen, A. | Krauss, J. | Weichert, W. | +4

8

Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

enthalten in: Radiation oncology | 2011

von Jensen, A. | Krauss, J. | Weichert, W. | +4

9

Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab : the NEAR trial

enthalten in: Cancer | 2011

von Jensen, A. | Münter, M. | Bischoff, H. | +6

10

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-C-HIT

enthalten in: BMC cancer | 2011

von Jensen, A. | Krauss, J. | Potthoff, K. | +6